• Psora 4: Redefining Kv1.3 Blocker Precision in T Cell Resear

  2026-07-29

  Explore how Psora 4, a selective Kv1.3 blocker, advances research on T cell Ca2+ signaling and autoimmune models with new insights into pharmacological modulation. This article uniquely analyzes the impact of channel architecture on blocker kinetics, guiding advanced immunology workflows.

• CHI3L1-IN-5 (Compound Z17): Next-Gen Neuroinflammation Inhib

  2026-07-29

  This thought-leadership article explores the mechanistic, translational, and strategic dimensions of CHI3L1-IN-5 (Compound Z17), a structure-activity relationship optimized inhibitor targeting the CHI3L1-mediated NF-κB pathway. Integrating recent mechanistic discoveries, validated workflows, and competitive context, it provides advanced guidance for leveraging this molecule in neurodegeneration research. The article also uniquely bridges current neuroinflammation paradigms with emerging cardiac protection data, articulating the implications and boundaries of cross-domain translation.

• Octyl-α-ketoglutarate: Prolyl Hydroxylase Substrate for HIF-

  2026-07-28

  Octyl-α-ketoglutarate is a cell-permeable α-ketoglutarate derivative that restores prolyl hydroxylase activity, enabling precise modulation of HIF-1α degradation under metabolic stress. As a robust research tool, it supports investigations into TCA cycle dysfunction and hypoxia signaling with validated performance in cancer metabolism models.

• SB-505124 Hydrochloride: Applied Workflows for TGF-β Pathway

  2026-07-28

  SB-505124 hydrochloride empowers researchers to dissect the TGF-β/activin pathway with precision, transforming fibrosis, cancer mechanobiology, and immune evasion assays. Learn how optimized protocols, troubleshooting strategies, and cross-domain insights make this selective ALK inhibitor an indispensable tool for advanced cell signaling studies.

• GLP-1 (9-36) amide: Redefining Antagonism in GLP-1R Pathway

  2026-07-27

  Explore the nuanced role of GLP-1 (9-36) amide as a glucagon-like peptide-1 receptor antagonist for advanced GLP-1 receptor signaling studies. This article offers a mechanistic deep dive and practical guidance for assay design, distinguishing itself from existing protocols and reviews.

• Reliable Assays with Tris(2-carboxyethyl) Phosphine Hydrochl

  2026-07-27

  This article explores how Tris(2-carboxyethyl) phosphine hydrochloride (TCEP hydrochloride, SKU B6055) addresses persistent laboratory challenges in cell viability, protein analysis, and advanced assay workflows. Drawing on recent research and validated protocols, we demonstrate the advantages of TCEP hydrochloride for reproducibility, sensitivity, and workflow safety in biomedical research.

• Dual-Action Kinase Inhibitors Facilitate p38α MAPK Dephospho

  2026-07-26

  The referenced study demonstrates that certain kinase inhibitors not only block p38α MAP kinase activity but also accelerate its dephosphorylation by phosphatases via conformational modulation. This dual-action mechanism opens new avenues for designing kinase inhibitors with enhanced specificity and functional impact in cell signaling research.

• TCAIM-Mediated Selective OGDH Degradation Regulates Mitochon

  2026-07-25

  This study uncovers TCAIM, a novel mitochondrial DNAJ protein, as a specific regulator of α-ketoglutarate dehydrogenase (OGDH) proteolysis, thereby modulating mitochondrial metabolism. The findings highlight a new post-translational mechanism for metabolic enzyme regulation, providing a foundation for targeted research into mitochondrial proteostasis and bioenergetics.

• SD 169 (indole-5-carboxamide): Structural Insights Fueling S

  2026-07-24

  Explore how SD 169 (indole-5-carboxamide) advances selective p38 MAPK inhibition through unique structural mechanisms, shaping the next generation of type 1 diabetes and neuroregeneration research. This article reveals how new conformational insights inform assay design and translational applications.

• LPS Protects Macrophages from Chemotherapy via System Xc− an

  2026-07-24

  This study dissects how lipopolysaccharide (LPS) selectively shields macrophages from chemotherapeutic toxicity through the activation of system Xc− and ABCC1-mediated pathways. These insights advance our understanding of immune cell preservation during cancer treatment and inform strategies for minimizing off-target drug effects.

• JC-1 in Translational Research: Mitochondrial Insights to Cl

  2026-07-23

  Explore how JC-1, a gold-standard fluorescent probe, empowers translational researchers to decode mitochondrial membrane potential dynamics in cancer and apoptosis studies. This article blends mechanistic insight with strategic guidance, referencing the latest evidence from anaplastic thyroid cancer research and APExBIO's high-quality JC-1, and sets a vision for next-generation mitochondrial assays.

• Pterostilbene Counters Dermal Fibroblast Senescence via Mito

  2026-07-23

  Zhou et al. (2025) reveal that pterostilbene, a natural polyphenol, delays human dermal fibroblast senescence by improving mitochondrial quality through enhanced mitophagy. This mechanistic insight highlights mitochondrial maintenance as a promising direction for dermal anti-aging research and informs future strategies for skin rejuvenation.

• Sodium Salicylate: Strategic NF-κB Inhibition for Translatio

  2026-07-22

  A thought-leadership article for translational researchers, exploring how sodium salicylate’s mechanistic specificity as an NF-κB inhibitor empowers the next generation of inflammation, oxidative stress, and tumor microenvironment studies. The piece integrates recent evidence from stromal remodeling in pancreatic cancer, protocol guidance, and a forward-looking perspective on stroma-targeted drug development.

• PreScission Protease (PSP): Technical Guidance for Tag Cleav

  2026-07-22

  PreScission Protease (PSP) enables precise removal of fusion tags from recombinant proteins, facilitating the recovery of native proteins in research workflows. It is ideally used in protein purification schemes where specificity and low-temperature activity are required. PSP is not suitable for applications lacking the Leu-Glu-Val-Leu-Phe-Gln-Gly-Pro cleavage site or where HRV 3C protease recognition is incompatible with the fusion construct.

• Toremifene in Breast Cancer: Insights for Endocrine Therapy

  2026-07-21

  The reference review synthesizes 20 years of clinical data on toremifene, a selective estrogen receptor modulator, highlighting its role and evidence base in hormone-sensitive breast cancer treatment. These insights inform the broader landscape of endocrine therapy, including the rational deployment of steroidal aromatase inhibitors such as exemestane in translational research.

456 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page